FDA InspectionCorePharma, LLC
CorePharma, LLC – FDA Inspection, Sep 12, 2024
Record Details
This FDA Inspection record concerns CorePharma, LLC, with an inspection on September 12, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
ID · debe7cb9-f65c-449a-8bd8-1fa4d1291653
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1240419
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of CorePharma, LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 29, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 11, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 24, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every CorePharma, LLC document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA